Table 2: Disease characteristics of patients with RVO.

Control cohort ( )Patients with RVO
( out of 47,166 persons)

Average age at diagnosis (years)n/a57
Overweight (BMI = 25–29.9 kg/m2) [ ]3799 (5%)17 (23%)
Obesity (BMI ≥ 30 kg/m2) [ ]1522 (2%)9 (13%)
BMI, male (mean ± SD)25 ± 13.928 ± 10
BMI, female (mean ± SD)24 ± 14.129 ± 9
Family history, type 2 diabetes [ ]782 (1%)2 (3%)
Smoking [ ]3804 (5%)13 (18%)
Hypertension [ ]10650 (14%)49 (68%)
 Systolic blood pressure (mean ± SD)131 ± 15.4143 ± 15
 Diastolic blood pressure (mean ± SD)77 ± 8.587 ± 10
Dyslipidemia [ ]7603 (10%)11 (16%)
History of impaired fasting glucose (IFG) [ ]0 (0%)0 (0%)
History of impaired glucose tolerance (IGT) [ ]780 (1%)1 (1%)
Glycosylated haemoglobin (HbA1C) (mean ± SD)6.3 ± 0.37.6 ± 1.3
History of vascular Disease [ ]9129 (12%)18 (25%)
Acute coronary syndrome (ACS) [ ]4567 (6%)5 (7%)
Myocardial infarction (MI) [ ]799 (1%)9 (12%)
Stroke [ ]714 (1%)4 (6%)
Percutaneous coronary transluminal arthroplasty (PCTA) [ ]689 (1%)1 (1%)
Coronary artery bypass graft (CABG) [ ]701 (1%)3 (3%)
Peripheral arterial disease (PAD) [ ]215 (<1%)2 (2%)
Congestive heart failure (CHF) [ ]755 (1%)0 (0%)
History gestational diabetes (females) [ ]181 (<1%)0 (0%)
Chronic kidney disease [ ]
 Stage 10 (0%)3 (3%)
 Stage 20 (0%)3 (3%)
 Stage 3737 (1%)2 (3%)
 Stage 42282 (3%)4 (5%)
 Stage 5 (end-stage renal disease)766 (1%)1 (1%)
 Dialysis(<1%)0 (0%)

Microvascular complications (%)5%0%